Keiko Matsumoto1, Yoshiharu Ohno2, Hisanobu Koyama2, Takeshi Yoshikawa2, Mizuho Nishio2, Yumiko Onishi2, Nobukazu Aoyama3, Daisuke Takenaka2, Kazuro Sugimura2
1Radiology, Yamanashi Hospital of Social Insurance, Kofu, Yamanashi, Japan; 2Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan; 3Radiology, Kobe University Hospital, Kobe, Hyogo, Japan
To the best of our knowledge, the capability of diffusion-weighted MR imaging (DWI) for prediction of therapeutic effect in advanced non-small cell carcinoma (NSCLC) patients with chemoradiotherapy as not yet been demonstrated. In the present study, we hypothesized that quantitatively assessed DWI can be utilized for prediction of therapeutic effect after chemoradiotherapy in NSCLC patients as well as FDG-PET/CT. Thus, the purpose of the present study was to directly and prospectively compare the predictive capability for therapeutic effect of chemoradiotherapy between DWI and FDG-PET/CT in NSCLC patients.